Seventy-Eight Percent of Chief IP Counsel for Pharmaceutical & Biotechnology Companies Say America Invents Act Has Changed the Patent Process, Consero Survey Reveals

January 2015 Contact Center Report
January 24, 2015
Corporate Counsel: Pharma and Biotech Getting in the Post-grant IP Game
January 26, 2015

Seventy-Eight Percent of Chief IP Counsel for Pharmaceutical & Biotechnology Companies Say America Invents Act Has Changed the Patent Process, Consero Survey Reveals

BETHESDA, Md- (Jan. 26, 2015) – As the two-year mark approaches since the America Invents Act (AIA) went into effect, more than three-quarters (78%) of Chief IP Officers say the AIA has altered their approach to the patent process, according to a new survey by Consero Group, an international leader in creating high-level, invitation-only events for senior executives.  The results were reported as part of the January 2015 IP Pharmaceuticals & Biotechnology Data Survey, compiled by Consero Group in partnership with CPA Global and CDS Legal.

The percentage of Chief IP Officers who reported the AIA – the federal statute that changed the patent process from a “first-to-invent” system to a “first-to-file” system – has changed their in-house approach to the patent process has increased over time. When the same question was asked in a 2013 survey, just 59 percent of Chief IP Counsel reported having altered their approach to obtaining patents.

Furthermore, the 2015 survey found that the AIA has made the process for Post-Grant Review and Inter Partes Review more complex for 68 percent of respondents.

“The protection of intellectual property in the pharmaceutical and biotechnology industries is vital to corporate success and to the innovations these companies bring to the world,” said Paul Mandell, Founder & CEO of Consero. “As more time has passed since the America Invents Act went into effect, an increasing percentage of Chief IP Officers report that the AIA has altered their approach to the patent process, as well as that the AIA has made the patent process increasingly complex.”

Additional Findings Included:

  • Most Chief IP Counsel Use Support: Eighty percent of surveyed executives said they use outside help to perform patentability analysis.
  • Large Majority Pursuing M&A to Enhance R&D: Seventy-eight percent of surveyed Chief IP Counsel reported that they are pursuing M&A opportunities in order to enhance their R&D pipeline.
  • Metrics Not Widely Used To Assess Value: Only 30 percent of those surveyed employ metrics to assess the value that the company’s IP generates.

The 2015 Data Survey for Chief IP Officers in the Pharmaceuticals and Biotechnology industries, developed in partnership with CDS Legal and CPA Globa, was conducted in conjunction with Consero’s industry-specific invitation-only events hosted by Consero Group in November 2014. A total of 41 responses were recorded.

About Consero

Founded in 2010, Consero Group is an international leader in creating industry-specific events for senior-level executives in the following areas: Legal, Compliance, Shared Services, Customer Experience, Finance, IT, HR, and Procurement, among others. With operations in the U.S. and in Europe, Consero is best known for transforming the executive experience through intimate, invitation-only programs in a sophisticated learning environment with high-level content. For more information on Consero, please visit

About CPA Global

CPA Global is the world leader in intellectual property management software and IP and legal support services. With offices across Europe, the United States and Asia Pacific, CPA Global supports many of the world’s best known corporations and law firms with a range of IP and broader legal services, helping them to manage risk, cost and capacity, and realize greater value for their businesses and IP assets. CPA Global helps clients manage valuable IP rights, such as patents, designs, and trademarks, while ensuring that IP portfolios are protected, maintained and regularly reviewed. CPA Global is also a market leader in the outsourced legal services sector, providing high quality and cost-efficient legal support services such as transaction support, document review, contract management, anti-bribery and compliance, and legal research through global delivery centers in Europe, the US and India. Founded in Jersey, Channel Islands in 1969, CPA Global today employs some 2,000 people, serving clients’ needs in 200 jurisdictions through its own offices and an extensive agent network. For further information, please visit:

About CDS Legal
CDS Legal is a leading full-service eDiscovery firm ranked No. 1 in 2014 by the U.S. National Law Journal for end-to-end eDiscovery and managed eDiscovery and litigation support. CDS’ people, technology, and culture of excellence are focused on significantly reducing our clients’ litigation costs while improving transparency, reducing risk, and increasing client satisfaction. The company offers corporations and law firms cost-effective alternatives, while achieving defensible, fast and effective service. CDS Legal is headquartered in New York, and works with the largest law firms in New York, Chicago, and Washington, D.C., as well as many litigation-intensive corporations.

Mark Pasetsky
Mark Allen & Company